ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,658Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 2888

$1.54M Total Retail Price of All Prescriptions

Rank: 64 out of 2888

781 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 781 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

22% of this provider’s 781 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 19,641 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LISINOPRIL 966 779 1 3
AMLODIPINE BESYLATE 872 741 2 5
FUROSEMIDE 856 693 3 6
LEVOTHYROXINE SODIUM 766 639 4 1
HYDROCODONE-ACETAMINOPHEN 765 457 S3 5 4
POTASSIUM CHLORIDE 697 564 6 14
OMEPRAZOLE 580 389 7 7
PRAVASTATIN SODIUM 575 445 8 12
SIMVASTATIN 568 461 9 2
METFORMIN HCL 497 369 10 8
TRAMADOL HCL 476 380 11 16
CITALOPRAM HBR 464 380 12 24
DONEPEZIL HCL 444 406 13 26
HYDROCHLOROTHIAZIDE 412 309 14 15
GABAPENTIN 384 248 15 13
FAMOTIDINE 370 275 16 75
CARVEDILOL 337 293 17 21
CLONIDINE HCL 325 260 18 39
NAMENDA 312 302 19 34
METOPROLOL TARTRATE 289 212 20 10
ZOLPIDEM TARTRATE 289 220 20 17
RANITIDINE HCL 287 245 22 56
ALENDRONATE SODIUM 261 219 23 23
WARFARIN SODIUM 256 213 24 22
NEXIUM 253 172 25 19
CYMBALTA 235 152 26 44
SERTRALINE HCL 219 142 27 27
ATENOLOL 215 153 28 25
MELOXICAM 214 148 29 31
LOSARTAN POTASSIUM 212 162 30 18
CRESTOR 210 119 31 20
DIVALPROEX SODIUM 206 138 32 100
FLUOXETINE HCL 202 143 33 83
MIRTAZAPINE 195 183 34 54
METOPROLOL SUCCINATE 188 157 35 11
FLUTICASONE PROPIONATE 185 133 36 32
DIOVAN 184 150 37 35
TRAZODONE HCL 164 126 38 43
PANTOPRAZOLE SODIUM 163 141 39 33
ATORVASTATIN CALCIUM 163 107 39 9
DIGOXIN 153 148 41 55
ALLOPURINOL 151 111 42 37
GLIMEPIRIDE 147 96 43 36
PROMETHAZINE HCL 143 81 R 44 96
SPIRIVA 136 90 45 79
TAMSULOSIN HCL 134 129 46 29
JANUVIA 132 86 47 48
LANTUS 128 75 48 45
NOVOLIN 70-30 120 86 49 144
LYRICA 120 47 49 69
LISINOPRIL-HYDROCHLOROTHIAZIDE 115 97 51 28
CLOPIDOGREL 114 84 52 30
ADVAIR DISKUS 110 67 53 60
INSULIN SYRINGE 109 67 54 86
METOCLOPRAMIDE HCL 109 73 54 116
LEVOFLOXACIN 108 77 56 57
SULFAMETHOXAZOLE-TRIMETHOPRIM 107 74 57 88
FENTANYL 107 61 S2 57 126
CARBIDOPA-LEVODOPA 106 76 59 113
RISPERIDONE 105 86 60 72
PREDNISONE 104 70 61 42
ALBUTEROL SULFATE 102 85 62 134
PLAVIX 101 76 63 40
LOSARTAN-HYDROCHLOROTHIAZIDE 100 90 64 46
PROAIR HFA 100 42 64 71
CELEBREX 98 84 66 89
CIPROFLOXACIN HCL 97 78 67 47
POLYETHYLENE GLYCOL 3350 94 70 68 93
CARISOPRODOL 94 33 R 68 82
QUETIAPINE FUMARATE 94 67 68 66
VENLAFAXINE HCL ER 93 42 71 120
AZITHROMYCIN 92 63 72 38
ESCITALOPRAM OXALATE 88 59 73 62
ROPINIROLE HCL 85 62 74 115
EXELON 84 84 75 106
PAROXETINE HCL 79 56 76 84
FENOFIBRATE 75 37 77 65
SINGULAIR 74 40 78 85
DIOVAN HCT 74 72 78 61
OXYBUTYNIN CHLORIDE 74 51 78 124
CYCLOBENZAPRINE HCL 71 22 R 81 68
OLANZAPINE 71 53 81 137
NITROGLYCERIN PATCH 69 65 83 183
BUSPIRONE HCL 69 30 83 148
NOVOLOG MIX 70-30 FLEXPEN 68 40 85 226
ISOSORBIDE MONONITRATE ER 68 44 85 51
BYSTOLIC 68 63 85 99
NYSTATIN 68 45 85 178
PEN NEEDLE 68 29 85 110
LEVETIRACETAM 67 38 90 103
SYMBICORT 66 47 91 142
SPIRONOLACTONE 62 46 92 70
SEROQUEL 62 48 92 143
IBUPROFEN 62 35 92 87
ATENOLOL-CHLORTHALIDONE 62 28 92 234
PREMARIN 62 42 R 92 129
NOVOLIN R 61 29 97 109
BENAZEPRIL HCL 61 43 97 77
PRADAXA 59 56 99 273
IPRATROPIUM-ALBUTEROL 59 51 99 150
HYDROXYZINE HCL 59 37 R 99 174
TRILIPIX 59 30 99 160
AMOX TR-POTASSIUM CLAVULANATE 58 40 103 112
DETROL LA 58 52 103 192
ABILIFY 58 28 103 172
GLYBURIDE 57 42 R 106 58
VENTOLIN HFA 56 25 107 173
TIZANIDINE HCL 55 46 108 133
NITROFURANTOIN MONO-MACRO 54 46 109 162
AMITRIPTYLINE HCL 53 32 R 110 74
ZYPREXA 52 28 111 399
VENLAFAXINE HCL 51 41 112 246
LEVEMIR FLEXPEN 51 40 112 156
TRICOR 50 31 114 91
VERAPAMIL HCL 50 36 114 368
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.